Sagami, R.; Sato, T.; Mizukami, K.; Motomura, M.; Okamoto, K.; Fukuchi, S.; Otsuka, Y.; Abe, T.; Ono, H.; Mori, K.;
et al. Diagnostic Strategy of Early Stage Pancreatic Cancer via Clinical Predictor Assessment: Clinical Indicators, Risk Factors and Imaging Findings. Diagnostics 2022, 12, 377.
https://doi.org/10.3390/diagnostics12020377
AMA Style
Sagami R, Sato T, Mizukami K, Motomura M, Okamoto K, Fukuchi S, Otsuka Y, Abe T, Ono H, Mori K,
et al. Diagnostic Strategy of Early Stage Pancreatic Cancer via Clinical Predictor Assessment: Clinical Indicators, Risk Factors and Imaging Findings. Diagnostics. 2022; 12(2):377.
https://doi.org/10.3390/diagnostics12020377
Chicago/Turabian Style
Sagami, Ryota, Takao Sato, Kazuhiro Mizukami, Mitsuteru Motomura, Kazuhisa Okamoto, Satoshi Fukuchi, Yuichiro Otsuka, Takashi Abe, Hideki Ono, Kei Mori,
and et al. 2022. "Diagnostic Strategy of Early Stage Pancreatic Cancer via Clinical Predictor Assessment: Clinical Indicators, Risk Factors and Imaging Findings" Diagnostics 12, no. 2: 377.
https://doi.org/10.3390/diagnostics12020377
APA Style
Sagami, R., Sato, T., Mizukami, K., Motomura, M., Okamoto, K., Fukuchi, S., Otsuka, Y., Abe, T., Ono, H., Mori, K., Wada, K., Iwaki, T., Nishikiori, H., Honda, K., Amano, Y., & Murakami, K.
(2022). Diagnostic Strategy of Early Stage Pancreatic Cancer via Clinical Predictor Assessment: Clinical Indicators, Risk Factors and Imaging Findings. Diagnostics, 12(2), 377.
https://doi.org/10.3390/diagnostics12020377
